The lawsuit accuses Walgreens of submitting prescription drug claims to BCBS at artificially inflated prices since 2007.
BCBS alleges that Walgreens inflated the prices by billing for inflated “usual and customary prices,” or the cost the general public would pay for prescriptions without going through insurance, instead of using a lower rate that many customers can get through its discount program, called the Prescription Savings Club.
As a result, “Walgreens has overcharged plaintiffs hundreds of millions of dollars for prescription drugs,” the lawsuit claims.
A Walgreens spokesperson declined Crain’s request for comment.
More articles on pharmacy:
CVS Health recruiting 50,000 workers amid COVID-19 pandemic
69 experimental COVID-19 drugs, treatments identified
Physicians found hoarding experimental COVID-19 treatments for relatives, report says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.